
This prospective and zzso study was conducted to evaluate clinical and economic consequences of using zzso zzso factor zzso following zzso peripheral blood zzso cell zzso transplantation in zzso Between January 1999 and December 2003, 117 patients underwent zzso zzso 51 patients received zzso following zzso while 66 patients did not receive zzso Median time to absolute zzso count zzso zzso zzso zzso was 10 days in the treatment group and 11 days in the control group zzso zzso zzso The median time to zzso zzso zzso zzso was 12 days in both groups zzso zzso zzso The median time to zzso zzso zzso zzso was 15 days in the zzso group and 14 days in the control group zzso In patients who received zzso zzso zzso zzso cells, the median time to zzso zzso zzso zzso and zzso zzso zzso was similar with or without zzso (12 and 15 days, zzso zzso zzso requirements were lower in the control group (2 vs 3 U in zzso zzso There was a trend towards higher total costs with zzso zzso zzso and zzso zzso with and without zzso respectively zzso zzso zzso Our data suggest that there is no indication of the standard application of zzso in children following zzso zzso The only possible indication is the group of patients with a lower yield of zzso zzso 

